The Oncology Precision Medicine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Oncology Precision Medicine Market?
The global market for oncology precision medicine has expanded swiftly in the past few years. The market which was valued at $110.90 billion in 2024 is projected to reach $125.14 billion in 2025, recording a compound annual growth rate (CAGR) of 12.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oncology Precision Medicine Industry?
The Oncology Precision Medicine Global Market Report 2025 projects that by 2029, the market size will reach $201.40 billion, growing at a compound annual growth rate (CAGR) of 12.6%.
Download Your Free Sample of the 2025 Oncology Precision Medicine Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Oncology Precision Medicine Market?
The key drivers in the oncology precision medicine market are:
• Growing prevalence of cancer is a significant growth driver
• Aging populations contribute to an increase in cancer cases
• Personalized treatments offered by precision medicine improve effectiveness and reduce side effects
• Rising number of new cancer cases annually propels market growth
Global Market Segmentation: Identifying Major Oncology Precision Medicine Industry Segments
The oncology precision medicine market covered in this report is segmented –
1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs
2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies
3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types
4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications
5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users
Pre-order the 2025 Oncology Precision Medicine Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Oncology Precision Medicine Market?
The key trends in the oncology precision medicine market are:
• The development of innovative solutions such as molecular tumor board initiatives by major market players is a key trend.
• The emergence of multidisciplinary collaboration for optimized personalized treatment planning is influencing the market.
• The increasing application of advanced genomic testing and targeted therapies in the healthcare sector is a significant trend.
• Companies are focusing on integrating education, technology enhancements, and operational assistance to deliver more personalized and effective cancer treatments.
Who Are the Top Competitors & Leading Players in the Oncology Precision Medicine Market?
Major players in the oncology precision medicine market are:
• Roche Holding AG
• Bristol Myers Squibb Company
• Abbott Laboratories
• Novartis AG
• Gilead Sciences Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• bioMérieux S.A.
• Bio-Rad Laboratories Inc.
• Exact Sciences Corporation
• Almac Group Limited
• OPKO Health Inc.
• Natera Inc.
• Myriad Genetics Inc.
• Pacific Biosciences of California Inc.
• Asuragen Inc.
• BGI Group
• ANGLE plc
Regional Dominance: Which Area Leads the Global Oncology Precision Medicine Market?
North America was the largest region in the oncology precision medicine market in 2024
